Detalhe da pesquisa
1.
Induction of innate lymphoid cell-derived interleukin-22 by the transcription factor STAT3 mediates protection against intestinal infection.
Immunity
; 40(1): 25-39, 2014 Jan 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-24412612
2.
STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors.
Immunity
; 41(5): 843-52, 2014 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-25517616
3.
USP22 deficiency in melanoma mediates resistance to T cells through IFNγ-JAK1-STAT1 signal axis.
Mol Ther
; 29(6): 2108-2120, 2021 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33601053
4.
Adaptive immune cells temper initial innate responses.
Nat Med
; 13(10): 1248-52, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17891146
5.
Cetuximab-mediated tumor regression depends on innate and adaptive immune responses.
Mol Ther
; 21(1): 91-100, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22990672
6.
Dysregulation of Wnt/ß-catenin signaling contributes to intestinal inflammation through regulation of group 3 innate lymphoid cells.
Nat Commun
; 15(1): 2820, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38561332
7.
A novel antagonist of the CCL5/CCR5 axis suppresses the tumor growth and metastasis of triple-negative breast cancer by CCR5-YAP1 regulation.
Cancer Lett
; 583: 216635, 2024 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38237887
8.
TANK-binding kinase 1 attenuates PTAP-dependent retroviral budding through targeting endosomal sorting complex required for transport-I.
J Immunol
; 186(5): 3023-30, 2011 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21270402
9.
A spike-targeting bispecific T cell engager strategy provides dual layer protection against SARS-CoV-2 infection in vivo.
Commun Biol
; 6(1): 592, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37264086
10.
T cell receptor ß-chain-targeting chimeric antigen receptor T cells against T cell malignancies.
Nat Commun
; 13(1): 4334, 2022 07 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35882880
11.
Hyper innate responses in neonates lead to increased morbidity and mortality after infection.
Proc Natl Acad Sci U S A
; 105(21): 7528-33, 2008 May 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-18490660
12.
Type I Interferon Promotes Antitumor T Cell Response in CRPC by Regulating MDSC.
Cancers (Basel)
; 13(21)2021 Nov 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34771735
13.
A CLDN18.2-Targeting Bispecific T Cell Co-Stimulatory Activator for Cancer Immunotherapy.
Cancer Manag Res
; 13: 6977-6987, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34522140
14.
Bcl-2 Enhances Chimeric Antigen Receptor T Cell Persistence by Reducing Activation-Induced Apoptosis.
Cancers (Basel)
; 13(2)2021 Jan 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33429845
15.
Engineering mesenchymal stromal cells with neutralizing and anti-inflammatory capability against SARS-CoV-2 infection.
Mol Ther Methods Clin Dev
; 21: 754-764, 2021 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34007862
16.
A chimeric antigen receptor with antigen-independent OX40 signaling mediates potent antitumor activity.
Sci Transl Med
; 13(578)2021 01 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33504651
17.
4-1BB Signaling Boosts the Anti-Tumor Activity of CD28-Incorporated 2nd Generation Chimeric Antigen Receptor-Modified T Cells.
Front Immunol
; 11: 539654, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33281809
18.
cGAS-STING-mediated DNA sensing maintains CD8+ T cell stemness and promotes antitumor T cell therapy.
Sci Transl Med
; 12(549)2020 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32581136
19.
Distinct contribution of PD-L1 suppression by spatial expression of PD-L1 on tumor and non-tumor cells.
Cell Mol Immunol
; 16(4): 392-400, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29568117
20.
Genome-Wide CRISPR Screening Identifies JAK1 Deficiency as a Mechanism of T-Cell Resistance.
Front Immunol
; 10: 251, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30837996